Dra. Gabriela Nora Cesarman-Maus.
Ponencia: Pruebas para diagnóstico de Von Willebrand
SNI Nivel II
Nacionalidad: Mexicana
Hematología y Oncología- The New York-Hospital, Cornell Medical Center.
Estudios
Especialidad
1989 (1° marzo 86 al 28 febrero 89)
Residencia en Medicina Interna en el INCMSZ
Sub-especialidad
1990-94 Residencia en Oncología Médica y en Hematología en el New York Hospital – Cornell Medical Center. N.Y. Grado obtenido: Médico Oncólogo y Hematólogo
1992-1994 Susan Murphy Fellow. Cornell Medical Center.
Doctorado en Ciencias
2006-2010 Doctorado en Ciencias Químico Biológicas IPN
Jefe del Servicio de Càncer y Trombosis, Depto Hematología INCan
Idiomas
Español, Ingles (100%), Frances, Iidish (aprox 70%)
Premios
Dr. Luis Sanchez Medal Award. Awarded by the Asociación Mexicana de Hematología
- Primer Lugar artículo de investigación Clínica. (Chile)
2013 Tercer lugar, artículo de investigación básica (Argentina)
2016 Tercer lugar artículo de investigación básica (Venezuela)
2018 Segundo lugar artículos de investigación clínica (Argentina)
2018 Tercer lugar artículos de investigación clínica (Argentina)
Otros
2019- Representante Nacional del Grupo Cooperativo Latino Americano de Hemostasia y Trombosis (CLAHT)
2016 Miembro Fundador y miembro del Comité Científico de la Sociead Mexicana de Trombosis y Hemostasia ( SOMETH)
2020 Miembro del COVID-TASK FORCE de la Sociedad Internacional de Trombosis y Hemostasia (ISTH)
2020 Revisor de trabajos libres COVID para el congreso ISTH Milan 2020.
2019 Miembro del Steering Committee del DIA MUNDIAL DE LA TROMBOSIS, ISTH, para la creación de estrategias de educación y difusión.
2007 Coordinadora del Servicio de Cáncer y Trombosis , INCan.
2019: Miembro del Comité de Women in Medicine,American Society of Hematology
2019: Miembro del comité de Women in Hematology American Society of Hematology
Referencias.
- Patricia Casais, Gabriela Cesarman-Maus, Cecilia Guillermo-Esposito , Raúl Izaguirre-Ávila, Rosario Martínez Rovira, Fernanda Andrade Orsi. Suely M. Rezende, Pautas de profilaxis y tratamiento antitrombótico para pacientes con covid-19. Consenso del Grupo Cooperativo Latinoamericano en Hemostasia y Trombosis (CLAHT). Revista Archivos de Cardiología de México. 2020 Aceptado,, en prensa
- Cesarman-Maus, Gabriela; Orsi, Fernanda; Amigo, Mary-Carmen; Sarmiento, Rosa SARS-CoV-2 sequence similarities to beta-2 glycoprotein-I may explain the presence of antiphospholipid antibodies in COVID-19 patients Lupus 2020 En revision editorial. Lupus.
- López-Salazar J1, Ramírez-Tirado LA2, Gómez-Contreras N2, Pacheco-Bravo I3, Cortés E2, Gallardo D2, Arrieta O2, Cesarman-Maus G. Cancer-associated prothrombotic pathways: leucocytosis, but not thrombocytosis, correlates with venous thromboembolism in women with ovarian cancer. Intern Med J. 2020 Mar;50(3):366-370. doi: 10.1111/imj.14762.
- Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3. Review.
- Pabinger I, van Es N, Heinze G, Posch F, Riedl J, Reitter EM, Di Nisio M, Cesarman-MausG, Kraaijpoel N, Zielinski CC, Büller HR, Ay C. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohort. Lancet Haematol. 2018 Jul;5(7):e289-e298. doi: 10.1016/S2352-3026(18)30063-2. Epub 2018 Jun 7.
- Sanchez D, Romero L, Lopez S et al. 18F-FDG-PET/CT in Canine Mammary Gland Tumors. Frontiers Vet. Sci. Aug. 2019. Doi.org/10.3389/fvets.2019.00280
- Sanchez D, Sanchez-Verin. Corona H et al. Canine Lymphoma: pathological and clinical characteristics of patients treated at a referral hospital. Veterinaria Mexico 2019, 6 (2) ISSN 2448-6760
- van Es N, Hisada Y, Di Nisio M, Cesarman G, Kleinjan A, Mahé I, Otten HM, Kamphuisen PW, Berckmans RJ, Büller HR, Mackman N, Nieuwland R. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res 2018 Jun;166:54-59. doi: 10.1016/j.thromres.2018.04.009. Epub 2018 Apr 10.
- Sánchez D, Cesarman-MausG, Amador-Molina A, Lizano M.Oncolytic Viruses for Canine Cancer Treatment.. Cancers (Basel). 2018 Oct 27;10(11). pii: E404. doi: 10.3390/cancers1011040
- PabingerI, van Es N, Heinze G, Posch F, Riedl J, Reitter EM, Di Nisio M, Cesarman-Maus G, Kraaijpoel N, Zielinski CC, Büller HR, Ay C.A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol. 2018 Jun 7. pii: S2352-3026(18)30063-2. doi: 10.1016/S2352-3026(18)30063-
- van Es N, Di Nisio M, Cesarman G, Kleinjan A, Otten HM, Mahé I, Wilts IT, Twint DC, Porreca E, Arrieta O, Stépanian A, Smit K, De Tursi M, Bleker SM, Bossuyt PM, Nieuwland R, Kamphuisen, PW, Büller HR. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study Haematologica. 2017 Sep;102(9):1494-1501.
- Volkow P, Cesarman-Maus G, Garciadiego-Fossas P, Rojas-Marin E, Cornejo-Juárez P. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma. AIDS Res Ther. 2017 May 30;14(1):30.
- Cesarman-Maus G, Ruiz-Argüelles GJ. News in the Indications of Direct Oral Anticoagulants According to the American College of Chest Physicians 2016 Guidelines. Curr Drug Metab. 2017;18(7):651-656.
- Fonseca R, Cesarman-Maus G, Braggio E.Personalizing the Use of Circulating Microparticle-Associated Tissue Factor as a Biomarker for Recurrent Thrombosis in Patients with Cancer. J Clin Oncol. 2017 Jul 1;35(19):2217-2218.Sánchez D, Pelayo R, Medina LA, Vadillo E, Sánchez R, Núñez L, Cesarman-Maus G, Sarmiento-Silva RE.Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma. 2015 Dec 23;8(1). pii: E3. doi: 10.3390/v801000.
- Cabrera-Fuentes HA, Alba-Alba C, Aragones J, Bernhagen J, Boisvert WA, Bøtker HE, Cesarman-Maus G, Fleming I, Garcia-Dorado D, Lecour S, Liehn E, Marber MS, Marina N, Mayr M, Perez-Mendez O, Miura T, Ruiz-Meana M, Salinas-Estefanon EM, Ong SB, Schnittler HJ, Sanchez-Vega JT, Sumoza-Toledo A, Vogel CW, Yarullina D, Yellon DM, Preissner KT, Hausenloy DJ. Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside. Basic Res Cardiol. 2016 Jan;111(1):7. doi: 10.1007/s00395-015-0527-0. Epub 2015 Dec 14.
- Meillón-García LA, Hernández-Zamora E, Montiel-Manzano G, Zavala-Hernández C, Ramírez-San Juan E, Cesarman-Maus G, Reyes-Maldonado E. Anticoagulant proteins in a population of Mexican mestizo donors. Ann Vasc Surg. 2015 Feb;29(2):222-6. doi: 10.1016/j.avsg.2014.09.023. Epub 2014 Nov 24.
- Cesarman-Maus G, Eteban Braggio, Carmen Lome-Maldonado, Ana Lilia Gómez-Leyte, Rafael Fonseca. Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell origin. Thrombosis Research 2014133 (4), 606–609
- Cesarman-Maus G, Meillón L, Volkow P, Vargas-Ruiz AG, Cornejo P, López-Navarro O, Moreno MC, Coronel O, García-Fernandez L, Ochoa-Carrillo FJ, Siñani M, Baz P, Izaguirre R. Tratamiento de Cáncer y Trombosis: enfoque práctico. Rev Invest Clin. 2013 Mar-Apr;65(2):174-82.
- Cesarman-Maus G, Villa R, Peter Kubisz, Monica Gonzalez-Ramirez, G. El síndrome de Plaquetas Pegajosas.(SPP) Revista de Hematología. 2013; 14 149-153
- Cesarman-Maus G, Eteban Braggio, Rafael Fonseca. Tissue factor and hematological neoplasias. Blood 2012, April 13 Re: Blood-2011-06-317685,
- Hedhli N, Falcone D, Huang B, Cesarman-Maus G. The Annexin A2/S100A10 System in health and disease: emerging paradigms. J. Biomed and Biotechnol 2012, (406273) pp:1-13
- Gabriela Cesarman-Maus, Esteban Braggio, Hector Maldonado, Rafael Fonseca. Absence of tissue factor expression by neoplatic plasma cells in multiple myeloma. Leukemia 2012, doi:10.1038/leu.2012.43 pag 1-4
- Gabriela Cesarman-Maus Esteban Braggio, Rafael Fonseca. Thrombosis in multiple myeloma. Hematology 2012. Vol 17, (suppl 1) pp. S1, S177 p.p 1-3
- Gabriela Cesarman-Maus. Myths and reality of Sticky platelet Syndrome. Rev Hematol Mex 2011; 12(2): 55-56.
- Gabriela Cesarman-Maus MD, PhD, Carlos Cantú-Brito MD, PhD, Fernando Barinagarrementeria MD, Rosario Villa, Elba Reyes PhD, Jorge Sanchez-Guerrero MD, Katherine A Hajjar MD, Ethel Garcia Latorre PhD. Autoantibodies against the Fibrinolytic Receptor, Annexin A2, in Cerebral Venous Thrombosis. Stoke. Adoi: 10.1161/Stroke AHA.110.592121 Feb 2011, 501-503.
- Escudero PM, y cols incluyendo Cesarman-Maus G. Parámetros de práctica clínica basados en evidencia en tromboprofilaxis. Trombosis y Cáncer. GAMO 2009, 08 (sup 4).
- Cesarman-Maus G, Rios-Luna P, Deora-Kumar A et al. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood, 2006 Jun 1;107(11):4375-82.
- Cesarman-Maus G, Hajjar KA. Annexin checks in – Response to Waisman. Br.J Haematol. 2005 Nov;131(4)
- Cesarman-Maus G. Hajjar K. Molecular Mechanisms of Fibrinolysis. Br.J.Haematol 2005 May;129(3):307-21
- Cesarman G. The Consular Program for Mexican Communities Abroad as a Source of Outreach for Health Workers. J Transcult Nurs 2003 14: 272-275.
- Montiel-Manzano G, de la Pena-Diaz A, Majluf-Cruz A, Cesarman-Maus G, Corona-de la Pena N, Cruz-Cruz D, Gaminio E, Martinez-Murillo C, Mayagoitia T, Miranda-Peralta E, Poblete T, Quintana-Martinez S, Ramirez Razo D, Ruiz de Chavez-Ochoa A, Reyes-Nunez VA, Salazar R, Vicencio-Santiago GV, Villa R. Evaluación Nacional del diagnóstico de la resistencia a la proteína C activada Rev Invest Clin. 2003 May-Jun;55(3):358-69.
- Gomez-Perez FJ, Aguilar-Salinas CA, Vazquez-Chavez C, Fanghanel-Salmon G, Gallegos-Martinez J, Gomez-Diaz RA, Salinas-Orozco S, Chavira-Lopez IJ, Sanchez-Reyes L, Torres-Acosta EM, Tamez R, Lopez A, Guillen LE, Cesarman G. Further insight on the hypoglycemic and nonhypoglycemic effects of troglitazone 400 or 600 mg/d: effects on the very-low-density and high-density lipoprotein particle distribution. Metabolism. 2002 Jan;51(1):44-51.
- G Anti-Annexin antibodies and Antiphospholipid / cofactor Syndrome. Memorias del XVII Congreso CLAHT. 2002,
- Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA.. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 1999 Apr 1;340(13):994- 1001
- Raffi S, Coleman M, Kaufmann T, Cesarman G, Papish SW, Bernhart B, Gaynor M, Reisman AM. CODBLAM IV chemotherapy for large cell lymphoma: sequential use of infusional vincristine and bleomycin and «high dose» consolidation. Am J Clin Oncol 1997 Feb;20(1):90-6
- Rojas G, Alberu J, Bordes-Aznar J, Quintanilla-Martinez L, Lome-Maldonado MC, Cesarman G, Angeles-Angeles A, Correa-Rotter Clinical and pathological characterization of posttransplantation lymphoproliferative disorders in kidney transplant recipients: single institution experience. R. Transplant Proc 1996 Dec;28(6):3317-20
- Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA dependent plasminogen activation. J Biol Chem 1994 Aug 19;269(33):21198-203
- Cesarman G, Cesarman E, Lagos G. Prevention and treatment of traveler’s diarrhea. N Engl J Med 1993 Nov
- Herrera MF, Lozano-Salazar RR, Bezaury P, Cesarman G, Hernandez G, Sanchez SA, Velazquez A, Lopez-Karpovitch X. Laparoscopic splenectomy in autoimmune thrombocytopenic purpura. Rev Invest Clin. 1998 Mar-Apr;50(2):127-32. Spanish.
- Cesarman G. Agentes Fibrinolíticos. Mecanismos de Acción, Beneficios y Desventajas. Programa Educativo AMEH, 1996
- Cesarman G. Enfermedad de Von Willebrand. Programa Educativo AMEH, 1996
- Cesarman G. Update on the Fibrinolytic, protein C and S Systems. Revista de Investigación Clínica. 1995 April 47 (1): 226-31 Spanish
- Rao PH, Cesarman G, Coleman M, Acaron S, Verma RS. Cytogenetic evidence for extramedullary blast crisis with t(8;13),(q11;p11) in chronic myelomonocytic leukemia. Acta Haematol 1992;88(4):201-04
- Sanchez-Guerrero J, Cesarman G, Alarcon-Segovia D. Massive pulmonary hemorrhage in mixed connective tissue diseases. J Rheumatol 1989 Aug;16(8):1132-4
- Guevara L, Cesarman G. Case Record. A 30-year-old woman with diabetes mellitus, generalized cutaneous hyperpigmentation and congestive heart failure. Rev Invest Clin 1986 Oct-Dec;38(4):429-33
- G. Angeles Angeles A. Pathological reclassification of non-Hodgkin´s lymphomas with the New Working Formulation. A retrospective review of clinical characteristics and outcomes. Archivos UNAM marzo1986.
- A M Silvia G Cesarman, I F Veja, L Mijares , A Cacho, M Pérez. Cáncer se vejiga avanzado” Advanced Bladder Cancer. Gamo Vol.5 Núm. 6 nov-dic 2006 pag.201 -204
Cesarman-Maus Gabriela “Actualidades en los Sistemas Fibrinolitico y de Proteinas C y S. La Revista de Investigación Cientifica. Suplemento 1 Vol. 47 Abril, 1995, pag. 16-19